Doraiswamy Vinayak 4

What Happened Vinayak Doraiswamy, Chief Scientific Officer of AtriCure (ATRC), sold 5,000 shares in an open-market transaction on March 12, 2026. The weighted average sale price was $29.83 per share, producing gross proceeds of approximately $149,150. This was a sale (transaction code S), which is generally a routine disposition rather than a buy signal.

Key Details

• Transaction date: March 12, 2026.
• Price: weighted average $29.83; executed in multiple trades at prices ranging from $29.79 to $29.92 per share (see footnote F1).
• Shares sold: 5,000; Gross proceeds ≈ $149,150.
• Shares owned after the transaction: Not specified in the filing.
• Footnote: The filing notes the sale was executed in multiple trades and the reporting person can provide full trade-by-trade details on request (F1).
• Timeliness: Filed March 16, 2026; the Form 4 was submitted within the required two business days after the March 12 transaction.

Context Sales by executives can reflect many reasons (portfolio rebalancing, tax planning, liquidity needs) and are not, by themselves, definitive signals about company prospects. This filing documents a straightforward open-market sale; no 10b5-1 plan, option exercise, gift, or tax-withholding event is reported.